The RAD Temp ensures uninterrupted cancer treatment in Northeast Texas as TRMC upgrades its vault and linear accelerator for more precise, advanced care....
Phase 3 AURA 1 trial meets primary endpoint paving way for new treatment option in China...
Quarterly intensive program now offers transformative rehab for more neurological conditions ...
New feature enables compatibility with almost any fluoroscopic C-arm, advancing global lung cancer diagnostics...
Unveiled at the ADLM Clinical Lab Expo 2025, UriVerse™ streamlines urine specimen handling with fully automated de-capping, barcode labelling, aliquoting, and re-capping—helping laboratories cut manual labour, reduce errors, and boost efficiency....
CEO Lawrence Florin discusses how human-relevant organ-on-a-chip systems and continuously updated digital twins are improving translational accuracy, reducing reliance on animal testing, and opening new frontiers in precision medicine....
The company’s second US LDT adds automated qFibrosis® analysis with stain-free SHG imaging, providing continuous, reproducible scores that cut inter-reader variability and support earlier, more personalised care. ...
PrecivityAD2 blood test is now available in over seven additional countries, with a primary focus on regions with inadequate PET infrastructure...
Project will leverage Ignite Proteomics’ reverse-phase protein array (RPPA) platform to profile tumour-immune signalling in breast cancer samples...
Acquisition will Accelerate Global Expansion of Company’s Breakthrough Edison® Histotripsy Platform and Non-Invasive Tumor Therapy ...
